UPDATED Sep 23, 2025
Discover French Pharmaceuticals & Biotech Growth Stocks that are on the CAC. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ALCOX | €0.38 | 4.7% | 40.1% | €29.2m | €1.50 | PS3.9x | E147.3% | n/a | ||
AELIS | €1.10 | -20.9% | -77.0% | €15.6m | €11.00 | PS6.4x | E130.3% | n/a | ||
ALONC | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | ||
MEDCL | €22.52 | 9.1% | 42.7% | €729.4m | €24.47 | PS26.9x | E91.4% | n/a | ||
ALPHE | €2.00 | 2.6% | -53.6% | €14.4m | €5.80 | PS4.6x | E78.8% | n/a | ||
EAPI | €3.03 | -0.7% | -25.7% | €290.4m | €3.08 | PB0.3x | E71.7% | n/a | ||
MAAT | €4.10 | -1.2% | -44.7% | €65.1m | €17.13 | PS16.8x | E68.8% | n/a | ||
ALDVI | €1.82 | 40.8% | 95.3% | €22.5m | €3.50 | PS4.9x | E65.8% | n/a | ||
NANO | €12.64 | 39.5% | 191.2% | €554.5m | €12.02 | PE-8.9x | E64.4% | n/a | ||
VLA | €4.47 | 6.3% | 65.2% | €738.4m | €6.51 | PS3.9x | E61.3% | n/a | ||
ALERS | €25.45 | 0.8% | 1.8% | €254.9m | €30.00 | PE63.9x | E57.6% | n/a | ||
ADOC | €7.78 | -1.5% | 37.7% | €142.2m | €16.00 | PS11.7x | E44.3% | n/a | ||
ALVAL | €0.80 | -4.4% | -38.9% | €12.9m | €3.00 | PS72.4x | E42.7% | n/a | ||
ALSEN | €0.32 | 5.4% | -57.9% | €94.7m | €2.38 | PS16.8x | E42.4% | n/a | ||
ABVX | €71.50 | 3.0% | 612.2% | €5.3b | €83.67 | PS897.1x | E41.5% | n/a | ||
ALOPM | €0.54 | -28.3% | -47.5% | €9.5m | €2.00 | PE1.6x | E41.5% | n/a | ||
IVA | €4.68 | 6.6% | 148.7% | €658.7m | €6.45 | PS46.1x | E41.4% | n/a | ||
BOI | €28.30 | 15.3% | -11.4% | €493.1m | €25.00 | PE43.3x | E31.0% | 4.2% | ||
IPH | €1.62 | -7.9% | -17.7% | €146.5m | €4.93 | PS11.8x | E30.2% | n/a | ||
DIM | €181.30 | 2.2% | 6.4% | €18.2b | €233.31 | PE78.3x | E25.8% | 0.4% | ||
ERF | €61.90 | -1.4% | 14.2% | €11.1b | €64.36 | PE28.9x | E23.2% | 1.0% | ||
DBV | €1.58 | -1.5% | 131.9% | €218.8m | €1.52 | PS67x | E22.5% | n/a | ||
VIRP | €312.00 | 0.5% | -19.7% | €2.6b | €395.22 | PE19.6x | E11.9% | 0.5% | ||
IPN | €114.90 | -0.4% | 4.5% | €9.4b | €128.43 | PE21.1x | E11.6% | 1.2% |